Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand

Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand

Abstract Background Hand, foot and mouth disease (HFMD) is endemic among population of young children in Thailand. The disease is mostly caused by enterovirus 71 (EV71) and coxsackievirus A16 (CA16). Methods This study conducted serosurveillance for neutralizing (NT) antibodies to EV71 subgenotypes...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Hatairat Lerdsamran, Jarunee Prasertsopon, Anek Mungaomklang, Chompunuch Klinmalai, Pirom Noisumdaeng, Kantima Sangsiriwut, Boonrat Tassaneetrithep, Ratigorn Guntapong, Sopon Iamsirithaworn, Pilaipan Puthavathana
Natura:	Articolo
Lingua:	English
Pubblicazione:	BMC 2018-10-01
Serie:	Virology Journal
Soggetti:	Hand foot and mouth disease Enterovirus 71 Coxsackievirus A16 Seroprevalence
Accesso online:	http://link.springer.com/article/10.1186/s12985-018-1074-8

Documenti analoghi

Complete genome analysis demonstrates multiple introductions of enterovirus 71 and coxsackievirus A16 recombinant strains into Thailand during the past decade
di: Pirom Noisumdaeng, et al.
Pubblicazione: (2018-12-01)

Molecular evolutionary dynamics of enterovirus A71, coxsackievirus A16 and coxsackievirus A6 causing hand, foot and mouth disease in Thailand, 2000–2022
di: Pirom Noisumdaeng, et al.
Pubblicazione: (2023-10-01)

Antiviral effect in association with anti-apoptosis and anti-autophagy of repurposing formoterol fumarate dihydrate on enterovirus A71-infected neuronal cells
di: Kachaporn Jintana, et al.
Pubblicazione: (2022-04-01)

Molecular characterization and geographical distribution of Zika virus worldwide from 1947 to 2022
di: Pirom Noisumdaeng, et al.
Pubblicazione: (2023-11-01)

T cell mediated immunity against influenza H5N1 nucleoprotein, matrix and hemagglutinin derived epitopes in H5N1 survivors and non-H5N1 subjects
di: Pirom Noisumdaeng, et al.
Pubblicazione: (2021-03-01)

Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response.
di: Don Changsom, et al.
Pubblicazione: (2016-01-01)

A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors.
di: Jutatip Panaampon, et al.
Pubblicazione: (2012-01-01)

Evaluation of different platforms for the detection of anti-SARS coronavirus-2 antibodies, Thailand
di: Hatairat Lerdsamran, et al.
Pubblicazione: (2021-12-01)

Higher correlation between neutralizing antibodies and surrogate neutralizing or binding antibodies in COVID-19 patients than vaccine recipients
di: Hatairat Lerdsamran, et al.
Pubblicazione: (2024-01-01)

Seroprevalence of anti-SARS-CoV-2 antibodies in Thai adults during the first three epidemic waves.
di: Hatairat Lerdsamran, et al.
Pubblicazione: (2022-01-01)

Coxsackieviruses B1–6 as Etiological Factor of Enterovirus Infection
di: N. I. Romanenkova, et al.
Pubblicazione: (2016-07-01)

Genotyping of non-polio enteroviruses associated with acute flaccid paralysis in Thailand in 2013 and 2014
di: Napa Onvimala, et al.
Pubblicazione: (2021-07-01)

Serostatus of echovirus 11, coxsackievirus B3 and enterovirus D68 in cord blood: The implication of severe newborn enterovirus infection
di: Ya-Li Hu, et al.
Pubblicazione: (2023-08-01)

Global landscape of coxsackieviruses in human health
di: Raiana S. Machado, et al.
Pubblicazione: (2024-06-01)

Enterovirus genotype diversity with emergence of coxsackievirus A2 circulating in pediatric patients with acute gastroenteritis in Thailand, 2019–2022
di: Zhenfeng Xie, et al.
Pubblicazione: (2024-06-01)

Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice
di: Elizabeth A. Caine, et al.
Pubblicazione: (2015-11-01)

Coxsackievirus A16 Encephalitis during Obinutuzumab Therapy, Belgium, 2013
di: Tom Eyckmans, et al.
Pubblicazione: (2014-05-01)

Primers and probe design and precision assessment of the real time RT-PCR assay in Coxsackievirus A10 and enterovirus detection
di: Jingfang Chen, et al.
Pubblicazione: (2017-06-01)

Antiviral Effects of Menthol on Coxsackievirus B
di: David J.R. Taylor, et al.
Pubblicazione: (2020-03-01)

Clinical and Genomic Epidemiology of Coxsackievirus A21 and Enterovirus D68 in Homeless Shelters, King County, Washington, USA, 2019–2021
di: Sarah N. Cox, et al.
Pubblicazione: (2024-11-01)

Safety and immunogenicity of an experimental live combination vaccine against enterovirus 71 and coxsackievirus A16 in rhesus monkeys
di: Ting Yang, et al.
Pubblicazione: (2020-07-01)

Molecular Epidemiology and Evolution of Coxsackievirus A14
di: Liheng Yu, et al.
Pubblicazione: (2023-11-01)

Echovirus 30 and coxsackievirus A9 infection among young neonates with sepsis in Iran
di: Abdolnabi Shabani, et al.
Pubblicazione: (2018-10-01)

The Evolution of Pleconaril: Modified <i>O</i>-Alkyl Linker Analogs Have Biological Activity towards Coxsackievirus B3 Nancy
di: Alexandrina Volobueva, et al.
Pubblicazione: (2020-03-01)

Antiviral Mechanisms of Saucerneol from <i>Saururus chinensis</i> against Enterovirus A71, Coxsackievirus A16, and Coxsackievirus B3: Role of Mitochondrial ROS and the STING/TKB-1/IRF3 Pathway
di: Jae-Hyoung Song, et al.
Pubblicazione: (2023-12-01)

Polyamine Analog Diethylnorspermidine Restricts Coxsackievirus B3 and Is Overcome by 2A Protease Mutation In Vitro
di: Bridget M. Hulsebosch, et al.
Pubblicazione: (2021-02-01)

Molecular Epidemiology and Evolution of Coxsackievirus A9
di: Hehe Zhao, et al.
Pubblicazione: (2022-04-01)

QSAR studies of BBR analogues against coxsackievirus B1
di: Babatunde Samuel Obadawo, et al.
Pubblicazione: (2022-01-01)

Computational Screening of Newly Designed Compounds against Coxsackievirus A16 and Enterovirus A71
di: Amita Sripattaraphan, et al.
Pubblicazione: (2022-03-01)

Serology supportive of recent coxsackievirus B infection is correlated with multisystem inflammatory syndrome in children (MIS-C)
di: Ramesh Kordi, et al.
Pubblicazione: (2025-03-01)

Hand, Foot, and Mouth Disease Caused by Coxsackievirus A6: A Preliminary Report from Istanbul
di: AYSE N. CEYLAN, et al.
Pubblicazione: (2019-06-01)

Hand, Foot, and Mouth Disease Caused by Coxsackievirus A6: A Preliminary Report from Istanbul
di: AYSE N. CEYLAN, et al.
Pubblicazione: (2019-06-01)

Conjuntivite hemorrágica aguda causada pela variante do coxsackievirus A24, em Belém, Pará, Brasil, 1987
di: Elisabeth de O. Santos, et al.
Pubblicazione: (1989-06-01)

Coxsackievirus B3 Activates Macrophages Independently of CAR-Mediated Viral Entry
di: Yasir Mohamud, et al.
Pubblicazione: (2024-09-01)

Atypical presentation of Hand foot mouth disease (HFMD) caused by enterovirus serotype Coxsackievirus A6, in India
di: Muruganandam Nagarajan, et al.
Pubblicazione: (2019-08-01)

Magnetic Resonance Imaging Features of Pediatric Coxsackievirus Encephalitis
di: Yang-Kai Fan, et al.
Pubblicazione: (2019-01-01)

Actividad antiviral del alga "Sargassum fluitans" (Børgesen) Børgesen 1914, frente al echovirus 9, el coxsackievirus A16 y el coxsackievirus A24
di: Liena de Regla Ponce Rey, et al.
Pubblicazione: (2021-07-01)

Detection and characterization of a coxsackievirus B2 strain associated with acute meningoencephalitis, Brazil, 2018
di: Ivanildo Pedro de Sousa Jr, et al.
Pubblicazione: (2020-11-01)

Fatal Coxsackievirus A-16 Pneumonitis in Adult
di: François Legay, et al.
Pubblicazione: (2007-07-01)

Rare occurrence of Coxsackievirus B4 along with Coxsackieviruses A6 and A10 from hand, foot and mouth disease
di: Sampada Tambolkar, et al.
Pubblicazione: (2023-07-01)